Peptide Screening Services | aptamer screening service|selexkmdbio.com
Info Center

Peptide Screening Services

Date:2025-12-09

What are Peptide Screening Services?

These are specialized contract research services offered by biotech companies and CROs (Contract Research Organizations) to discover, optimize, or validate peptide-based molecules for various applications. They provide the expertise, libraries, and high-throughput technologies to efficiently identify peptide hits from vast molecular collections.

Core Types of Peptide Screening Services

1. Library-Based Screening

This is the most common starting point for discovery.

  • Synthetic Peptide Libraries: Collections of thousands to millions of chemically synthesized peptides.

    • Positional Scanning Libraries: For epitope mapping or identifying key amino acid residues.

    • Truncation & Alanine Scanning: To find the minimal active sequence and critical residues.

  • Phage Display Libraries: The largest and most diverse format (up to 10^11 unique sequences). A library of bacteriophages, each displaying a unique peptide on its coat protein, is panned against a target (e.g., a protein, cell).

  • mRNA/Ribosome Display Libraries: Cell-free systems that link the peptide to its encoding mRNA, allowing for even larger libraries and easier mutagenesis.

2. Functional & Application-Specific Screening

Services are tailored to the desired peptide function:

  • Target-Based Screening: Against purified proteins (e.g., enzymes, receptors, GPCRs, protein-protein interaction interfaces).

  • Cell-Based Screening: For peptides that modulate cell signaling, internalize into cells (CPPs), or have antimicrobial (AMP) or anticancer activity.

  • Antigen/Antibody Screening: For epitope mapping, vaccine development, or diagnostic reagent discovery.

  • Anti-Microbial Peptide (AMP) Screening: Specialized assays against bacteria, fungi, or biofilms.

  • Material-Binding Peptide Screening: To discover peptides that bind to inorganic surfaces (e.g., gold, graphene, polymers) for nanotechnology or coatings.

3. Hit Validation & Characterization

Moving from initial “hits” to confirmed “leads”:

  • SPR (Surface Plasmon Resonance) & BLI (Bio-Layer Interferometry): For measuring binding affinity (KD) and kinetics (kon/koff).

  • ELISA & Competitive Binding Assays: To confirm specificity and potency.

  • Mass Spectrometry Analysis: For verifying sequence and post-translational modifications.

  • Stability & Serum Half-Life Studies: In various biological matrices.

4. Peptide Optimization & Engineering

Once a lead is identified, services to improve its properties:

  • Peptidomimetics & Stabilization: Incorporating D-amino acids, non-natural amino acids, cyclization (head-to-tail, disulfide), or PEGylation to enhance stability, half-life, and activity.

  • Affinity Maturation: Creating secondary libraries based on the lead sequence to improve binding strength.

  • Conjugation Services: Linking peptides to fluorophores, biotin, drugs, or carriers.

Common Workflow with a Service Provider

  1. Consultation & Design: Define target, assay, and success criteria.

  2. Library Selection/Design: Choose the appropriate library type and diversity.

  3. High-Throughput Screening (HTS): Perform the primary screen.

  4. Hit Identification & Sequencing: Retrieve the sequences of active peptides.

  5. Hit Validation & Characterization: Confirm activity with purified hits.

  6. Lead Optimization (Optional): Improve the pharmacological properties.

  7. Data & Report Delivery: Including sequences, analytical data, and recommendations.

Key Considerations When Choosing a Provider

Factor Questions to Ask
Expertise & Track Record Do they have experience in your specific field (e.g., oncology, neuroscience, diagnostics)? Can they provide case studies?
Technology & Library What library platforms do they offer (phage, synthetic, etc.)? What is the diversity and quality? Do they have a proprietary platform?
Assay Development Can they develop a custom assay for your unique target? Do they have robust in-house cell culture and protein production?
End-to-End Capability Can they take you from discovery through optimization and even to GMP manufacturing?
Data & Reporting What level of data (raw and analyzed) is provided? Is the process transparent?
Cost & Timeline What is the pricing model (project-based, FTE)? What are the typical milestones and delivery times?
Confidentiality & IP Who owns the intellectual property for the discovered sequences? How is data security handled?

Examples of Leading Service Providers (Illustrative)

  • Large CROs: Eurofins Discovery, Charles River Laboratories, WuXi AppTec.

  • Specialized Peptide Companies: CPC Scientific, Mimotopes, JPT Peptide Technologies, GenScript, Peptide 2.0.

  • Phage Display Specialists: Dyax (now part of Takeda), Creative Biolabs, Absolute Antibody.

Summary

Peptide screening services offer a powerful, outsourced pathway to accelerate peptide drug discovery, diagnostic tool development, and basic research. By leveraging their specialized libraries, automation, and expertise, researchers can bypass the need for extensive in-house infrastructure and focus on their core biological questions.

To get started, clearly define your target, desired peptide function, and success criteria, then engage with providers for detailed project proposals.